
    
      Primary objective:

      What is the effect on mood and anxiety symptoms of adding CPAP to the psychiatric treatment
      of patients with TRD and associated OSA?

      Secondary objectives:

        1. How common is co-morbid OSA in patients with treatment resistant unipolar depression
           referred to a tertiary Mood Disorders Clinic?

        2. Is there a difference in daytime functioning (severity of depressive and anxiety
           symptoms, cognitive function, daytime sleepiness) and sleep quality between patients
           with TRD diagnosed with OSA compared with patients with TRD who have no OSA?

        3. What is the association between sleep fragmentation and hypoxemia and the severity of
           depression in patients with TRD?
    
  